Skip to main content

Arabesque Asset Management Ltd

SEC CIK
0001766393
Latest filing
May 15, 2023

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by Arabesque Asset Management Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overviewAll 13F holders of HALOFull Q1 2023 holdings

Shares (Q3 2022)
0
Sold out in Q3 2022
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q2 2022
Holdings of HALO by Arabesque Asset Management Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20220$00.0%−7,819−100.0%Sold outHolders
Q2 20227,819$344.0K0.2%+7,819NewHolders